NCT05785520View on ClinicalTrials.gov

"Evaluation of the ST500 SINGLE- DOSE GEL in Patients With Symptomatic Long Head of the Biceps Tendon Injury"

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
Long Head of Biceps Rupture
Interventions
DEVICE

ST500 SINGLE-DOSE GEL

ST500 SINGLE-DOSE GEL is a hydrogel to be applied to intact skin, useful to limit the physiological degeneration of the joints and tissues, improving their functionality. The presence of a peptide mixture and sodium hyaluronate facilitates the movement of joints and tendons for greater mobility and flexibility.

Trial Locations (1)

21016

Ospedale Luini Confalonieri, Luino

All Listed Sponsors
lead

Contrad Swiss SA

INDUSTRY

NCT05785520 - "Evaluation of the ST500 SINGLE- DOSE GEL in Patients With Symptomatic Long Head of the Biceps Tendon Injury" | Biotech Hunter | Biotech Hunter